Drug absorption by the respiratory mucosa: Cell culture models and particulate drug carriers

C. Ehrhardt, J. Fiegel, S. Fuchs, R. Abu-Dahab, U. F. Schaefer, J. Hanes, Claus M. Lehr

Research output: Contribution to journalArticle

Abstract

The inhalation route is of increasing interest for both local and systemic drug delivery, including macromolecular biopharmaceuticals, such as peptides, proteins, and gene therapeutics. In addition to appropriate aerosolization for deposition in relevant areas of the respiratory tract, therapeutic molecules may require an advanced carrier system for safe and efficient delivery to their target. Two approaches to obtain novel carrier systems for pulmonary drug delivery are large porous microparticles with a low aerodynamic diameter and lectin-functionalized liposomes. Epithelial cells of alveolar or bronchial origin, obtained either from patient material or from established cell lines, can be grown on permeable filter supports, resulting in polarized monolayers with functional intercellular junctions. With such in vitro models, transport of drugs into pulmonary epithelial cells and/or across the air-blood barrier, as well as the effect and efficacy of novel drug carrier systems can be systematically studied.

Original languageEnglish (US)
Pages (from-to)131-139
Number of pages9
JournalJournal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung
Volume15
Issue number2
DOIs
StatePublished - Jan 1 2002

Keywords

  • Air-interface culture
  • Alveolar epithelial cells
  • Bronchial epithelial cells
  • Lectins
  • Liposomes
  • Microparticles

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Drug absorption by the respiratory mucosa: Cell culture models and particulate drug carriers'. Together they form a unique fingerprint.

  • Cite this